Drug Type Small molecule drug |
Synonyms CR-2945 |
Target |
Action antagonists |
Mechanism CCKB antagonists(Cholecystokinin B receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC33H38N2O4 |
InChIKeyMFOOVZCXWVAWOV-RUZDIDTESA-N |
CAS Registry201605-51-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anxiety Disorders | Phase 2 | Italy | - | |
| Dyspepsia | Phase 2 | - | - | |
| Gastroesophageal Reflux | Phase 2 | - | - | |
| Gastrointestinal Neoplasms | Phase 2 | Italy | - | |
| Peptic Ulcer | Phase 2 | - | - | |
| Sleep Apnea Syndromes | Phase 2 | Italy | - | |
| Sleep Apnea Syndromes | Phase 2 | - | - |





